211 related articles for article (PubMed ID: 34712723)
1. Establishment of a New Cell Line of Canine Mammary Tumor CMT-1026.
Mei C; Xin L; Liu Y; Lin J; Xian H; Zhang X; Hu W; Xia Z; Wang H; Lyu Y
Front Vet Sci; 2021; 8():744032. PubMed ID: 34712723
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a new cell line of canine inflammatory mammary cancer: IPC-366.
Caceres S; Peña L; de Andres PJ; Illera MJ; Lopez MS; Woodward WA; Reuben JM; Illera JC
PLoS One; 2015; 10(3):e0122277. PubMed ID: 25807360
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of a new triple-negative canine mammary cancer cell line.
Zhang H; Pei S; Zhou B; Wang H; Du H; Zhang D; Lin D
Tissue Cell; 2018 Oct; 54():10-19. PubMed ID: 30309498
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of a HER2-enriched canine mammary cancerous myoepithelial cell line.
Chen A; Ye S; Zheng J; Li J; Chen Z; Zhang Y; Li S
BMC Vet Res; 2023 Jan; 19(1):22. PubMed ID: 36717813
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of a multi-drug resistant cell line for canine mammary tumors.
Zhou C; Lin Z; Li X; Zhang D; Song P
Front Vet Sci; 2023; 10():1129756. PubMed ID: 37077947
[TBL] [Abstract][Full Text] [Related]
6. Characterization of protein marker expression, tumorigenicity, and doxorubicin chemoresistance in two new canine mammary tumor cell lines.
Hsiao YL; Hsieh TZ; Liou CJ; Cheng YH; Lin CT; Chang CY; Lai YS
BMC Vet Res; 2014 Sep; 10():229. PubMed ID: 25267010
[TBL] [Abstract][Full Text] [Related]
7. A Novel Canine Mammary Cancer Cell Line: Preliminary Identification and Utilization for Drug Screening Studies.
Li R; Wu H; Sun Y; Zhu J; Tang J; Kuang Y; Li G
Front Vet Sci; 2021; 8():665906. PubMed ID: 34124226
[TBL] [Abstract][Full Text] [Related]
8. Somatic Mutation of
Lee KH; Hwang HJ; Noh HJ; Shin TJ; Cho JY
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31842489
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-to-Mesenchymal Transition and Phenotypic Marker Evaluation in Human, Canine, and Feline Mammary Gland Tumors.
Sammarco A; Gomiero C; Beffagna G; Cavicchioli L; Ferro S; Michieletto S; Orvieto E; Patruno M; Zappulli V
Animals (Basel); 2023 Feb; 13(5):. PubMed ID: 36899736
[TBL] [Abstract][Full Text] [Related]
10. Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer?
Burrai GP; Tanca A; De Miglio MR; Abbondio M; Pisanu S; Polinas M; Pirino S; Mohammed SI; Uzzau S; Addis MF; Antuofermo E
Tumour Biol; 2015 Nov; 36(11):9083-91. PubMed ID: 26088453
[TBL] [Abstract][Full Text] [Related]
11. Current biomarkers of canine mammary tumors.
Kaszak I; Ruszczak A; Kanafa S; Kacprzak K; Król M; Jurka P
Acta Vet Scand; 2018 Oct; 60(1):66. PubMed ID: 30373614
[TBL] [Abstract][Full Text] [Related]
12. Canine Spindle Cell Mammary Tumor: A Retrospective Study of 67 Cases.
Alonso-Diez Á; Ramos A; Roccabianca P; Barreno L; Pérez-Alenza MD; Tecilla M; Avallone G; Gama A; Peña L
Vet Pathol; 2019 Jul; 56(4):526-535. PubMed ID: 30857503
[TBL] [Abstract][Full Text] [Related]
13. Immortalization and characterization of a new canine mammary tumour cell line FR37-CMT.
Raposo LR; Roma-Rodrigues C; Faísca P; Alves M; Henriques J; Carvalheiro MC; Corvo ML; Baptista PV; Pombeiro AJ; Fernandes AR
Vet Comp Oncol; 2017 Sep; 15(3):952-967. PubMed ID: 27140424
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-21 expression, serum tumor markers, and immunohistochemistry in canine mammary tumors.
Ramadan ES; Salem NY; Emam IA; AbdElKader NA; Farghali HA; Khattab MS
Vet Res Commun; 2022 Jun; 46(2):377-388. PubMed ID: 34787777
[TBL] [Abstract][Full Text] [Related]
15. Wnt/β-Catenin and Hippo Pathway Deregulation in Mammary Tumors of Humans, Dogs, and Cats.
Sammarco A; Gomiero C; Sacchetto R; Beffagna G; Michieletto S; Orvieto E; Cavicchioli L; Gelain ME; Ferro S; Patruno M; Zappulli V
Vet Pathol; 2020 Nov; 57(6):774-790. PubMed ID: 32807036
[TBL] [Abstract][Full Text] [Related]
16. Expression of different phenotypes in cell lines from canine mammary spindle-cell tumours and osteosarcomas indicating a pluripotent mammary stem cell origin.
Hellmén E; Moller M; Blankenstein MA; Andersson L; Westermark B
Breast Cancer Res Treat; 2000 Jun; 61(3):197-210. PubMed ID: 10965996
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of the KLF4 transcription factor inhibits the proliferation and migration of canine mammary tumor cells.
Tien YT; Chang MH; Chu PY; Lin CS; Liu CH; Liao AT
Vet J; 2015 Aug; 205(2):244-53. PubMed ID: 25616642
[TBL] [Abstract][Full Text] [Related]
18. Canine mammary tumors as a model for human disease.
Abdelmegeed SM; Mohammed S
Oncol Lett; 2018 Jun; 15(6):8195-8205. PubMed ID: 29928319
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a new cell line of canine inflammatory mammary cancer: IMC-118.
Gao H; Zhou H; Gao Y; He L; Li W; Xu M; Feng H; Feng X; Qiu C
Vet Comp Oncol; 2022 Sep; 20(3):679-687. PubMed ID: 35429113
[TBL] [Abstract][Full Text] [Related]
20. The dog as a natural animal model for study of the mammary myoepithelial basal cell lineage and its role in mammary carcinogenesis.
Rasotto R; Goldschmidt MH; Castagnaro M; Carnier P; Caliari D; Zappulli V
J Comp Pathol; 2014; 151(2-3):166-80. PubMed ID: 24975897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
